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remains poorly understood. The goal of this article was to examine
whether physician social networks—as deﬁned by shared patients—
are associated with rates of complications after radical prostatec-
tomy.Methods: In ﬁve cities, we constructed networks of physicians
on the basis of their shared patients in 2004-2005 Surveillance,
Epidemiology and End Results-Medicare data. From these networks,
we identiﬁed subgroups of urologists who most frequently shared
patients with one another. Among men with localized prostate
cancer who underwent radical prostatectomy, we used multilevel
analysis with generalized linear mixed-effect models to examine
whether physician network structure—along with speciﬁc character-
istics of the network subgroups—was associated with rates of 30-day
and late urinary complications, and long-term incontinence after
accounting for patient-level sociodemographic, clinical factors, and
urologist patient volume. Results: Networks included 2677 men in
ﬁve cities who underwent radical prostatectomy. The unadjustedee front matter Copyright & 2014, International S
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ndence to: Craig Evan Pollack, Johns Hopkins Schoorate of 30-day surgical complications varied across network sub-
groups from an 18.8 percentage-point difference in the rate of
complications across network subgroups in city 1 to a 26.9
percentage-point difference in city 5. Large differences in unadjusted
rates of late urinary complications and long-term incontinence
across subgroups were similarly found. Network subgroup character-
istics—average urologist centrality and patient racial composition—
were signiﬁcantly associated with rates of surgical complications.
Conclusions: Analysis of physician networks using Surveillance,
Epidemiology and End Results-Medicare data provides insight into
observed variation in rates of complications for localized prostate
cancer. If validated, such approaches may be used to target future
quality improvement interventions.
Keywords: cancer, claims data, health services, outcomes research.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Although variation in care across different geographic areas has
been widely described since the 1970s [1], there has been
increased recognition of variation within particular locales [2].
The potential mechanisms underlying this variation between and
across areas remain poorly understood. Physician networks
based on shared patients may be one tool to help better delineate
variation in care. In patient-sharing networks, physicians are
considered connected to one another if they provide care to the
same patient [3]. Patient-sharing networks signal connections
between physicians such as those based on practice structure
and hospital afﬁliation [4–6]. Importantly, they also represent
informal connections between physicians including referral pat-
terns and advice seeking [3]. By reﬂecting both formal andinformal connections that may shape clinical practice, physician
patient-sharing networks may provide insight into variation in care.
Physician patient-sharing networks have been associated with
the costs and intensity of medical care within geographic areas [7].
In the setting of prostate cancer, physician patient-sharing net-
works have been associated with the likelihood of receiving a
radical prostatectomy for localized disease within three cities [6].
We seek to extend previous work by exploring whether physician
patient-sharing networks are associated with variation in compli-
cations after radical prostatectomy for prostate cancer.
Complications after radical prostatectomy are an important
case study. In the United States, an estimated 238,590 men
received a diagnosis of prostate cancer in 2013 [8]. The decision
to undergo radical prostatectomy—a common treatment modal-
ity for men with localized disease [9]—is preference-sensitive.ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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month after surgery as well as longer term urinary incontinence
and erectile dysfunction [10–12]. Although research has demon-
strated that men who undergo radical prostatectomy by
high-volume surgeons and at high-volume institutions are less
likely to have complications [13–15], relatively little is known
about the reasons underlying variations in the rates of compli-
cations [16,17].
Within ﬁve cities, we constructed patient-sharing networks
composed of urologists, primary care providers (PCPs), and
radiation oncologists who care for patients with prostate cancer.
We then examined whether the network structure was associ-
ated with different rates of complications after radical prostatec-
tomy. Our underlying hypothesis was that patients seen by
providers who more frequently share patients with one another
may have similar rates of complications, after adjusting for
patients’ clinical and sociodemographic characteristics.
We further explored whether particular characteristics of
these network subgroups were associated with differences in
rates of complications. We focused on two network character-
istics—the average importance (centrality) of the doctors and the
proportion of minority patients in the network subgroups. Doc-
tors who are important in the network structure may have
achieved their prestige by providing higher quality of care and
may play an important role in shaping local norms and behaviors
[18]. We hypothesized that patients treated by network sub-
groups with higher levels of importance would have lower like-
lihood of complications. The disparities literature has shown that
health care providers [19] and institutions [20,21] who treat a
disproportionate share of minority patients may have greater
difﬁculty providing high-quality care. Thus, patients treated by
network subgroups with a high proportion of minority patients
were hypothesized to have lower quality of care.Methods
Study Design
The study was a retrospective, observational cohort study using
registry and administrative claims data from the Surveillance,
Epidemiology and End Results (SEER)-Medicare database. The
study was approved by the institutional review boards at the
University of Pennsylvania and Johns Hopkins University School
of Medicine.
Data Sources
The SEER-Medicare database links patients’ demographic and
tumor-speciﬁc data collected by SEER cancer registries to longi-
tudinal health care claims for Medicare enrollees [22]. Data on
physicians’ specialties were available from the Medicare Physi-
cian Identiﬁcation and Eligibility Registry ﬁle linked through
Unique Provider Identiﬁcation Numbers.
Study Population
We identiﬁed men aged 65 years or older living in ﬁve cities with
prostate cancer diagnosed between January 1, 2004, and Decem-
ber 31, 2005, in SEER, with follow-up through December 31, 2006,
in Medicare. Two years of data were analyzed to allow for
adequate connectivity of the networks based on our preliminary
analyses. Cities were deﬁned on the basis of US Census deﬁni-
tions of Combined Statistical Areas, which refer to cities and the
surrounding areas that are linked by economic and social activity
(http://www.census.gov/population/www/metroareas/metrodef.
html). Combined Statistical Areas represent a larger geographic
region than do health referral regions, as preliminary analysesrevealed that urologists cared for high numbers of patients from
multiple, adjacent health referral regions. Cities were included if
they had at least 200 patients who underwent prostatectomy
across the 2 years and SEER-Medicare included the great majority
of the geographic area. We do not present city names to ensure
patient and doctor conﬁdentiality.
Data on patients with incomplete Medicare records (i.e., those
enrolled in health maintenance organizations or not enrolled in
fee-for-service Medicare program) were excluded. For the con-
struction of the patient-sharing networks and deﬁnition of net-
work subgroups (see below), we included all men without
metastatic disease (N ¼ 13,465). We then used these network
subgroups in analyses that examined prostatectomy complica-
tions for a more homogeneous patient cohort. Speciﬁcally, we
limited the sample to men with American Joint Committee on
Cancer 6th edition stage 2 and 3 disease who underwent radical
prostatectomy (N ¼ 2974). Prostatectomy was identiﬁed from
Medicare inpatient, outpatient, and physician/supplier compo-
nent ﬁles as described previously [23]. We excluded those with
node-positive disease (N ¼ 59), unknown Gleason grade (N ¼ 13),
men who could not be matched to their surgical urologist (N ¼
225), and, because of their small sample size, men with stage 1
disease (N ¼ 107). The ﬁnal analytic sample size was 2677.Deﬁnition of Variables
Complications
Complications were deﬁned according to the work of Begg et al.
[13] using International Classiﬁcation of Diseases, Ninth Revision
diagnosis and procedural codes. Thirty-day surgical complica-
tions included cardiac, respiratory, vascular, wound, genitouri-
nary, miscellaneous medical, miscellaneous surgical, and blood
transfusion complications. Late urinary complications were
deﬁned as occurring from 31 to 365 days after surgery and
included bladder neck obstruction, uretheral stricture, intestinal
ﬁstula, lymphocele, cystitis/bleeding, and deﬁnitive incontinence
repair. Long-term incontinence was deﬁned as occurring 18
months or more after the surgery [24].Explanatory variables
Gleason grade was categorized as less than 7, 7, and 8 to 10.
Prostate-speciﬁc antigen level at the time of diagnosis was
classiﬁed as 4 ng/mL or less, more than 4 ng/mL to less than 10
ng/mL, 10 ng/mL or greater, or unknown. Patient comorbidities
were identiﬁed by classifying all available inpatient and out-
patient Medicare claims for the 90-day interval preceding pros-
tate cancer diagnosis into 46 categories [25], and, for clarity,
reported as 0, 1, or 2 or more. Race was classiﬁed from both SEER
and Medicare sources, and individuals were classiﬁed as white if
they did not have a classiﬁcation of black, Hispanic, or Asian in
either data ﬁle or as nonwhite. Area-level U.S. Census informa-
tion was used as a proxy for individual measures of socio-
economic status. Men were linked to their census tract and,
when not available, ZIP code to determine median income, which
was categorized into quartiles on the basis of sample distribution
in each city. Urologist surgical volume was deﬁned as the number
of radical prostatectomies performed over the 2-year period, with
high volume deﬁned as the top quartile in a given city (cutoff
point for high volume ranged from 16 to 41) [13].Network creation
We created networks for each city in which doctors were
connected to one another via shared patients. From each net-
work, we then sought to identify subgroups of doctors who
frequently share patients with one another (as deﬁned below).
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We focused on the following doctors who were most likely to be
involved in the patients’ prostate cancer care and thus most
likely to directly or indirectly interact. These included the surgical
urologist (deﬁned as the urologist who billed for the prostatec-
tomy), diagnosing urologist (deﬁned as the urologist who billed
for a claim on or closest to the date of the patient’s diagnosis),
PCP [26], plurality provider (the doctor, regardless of specialty,
who billed for the greatest number of claims in the 12 months
before diagnosis) [26], and radiation oncologist (among men who
underwent external beam or brachytherapy, the provider who
performed the clinical planning and simulation). PCPs were
included in the network structure on the basis of their role in
prostate cancer screening (typically through prostate-speciﬁc
antigen testing) and referral for diagnosis, which may help shape
the network structure.
Network construction
Networks were constructed using data from all patients without
metastatic disease and all their providers as described above. In
these networks, providers (represented by vertices or nodes) were
linked to one another by shared patients (termed edges). The
strength of connection between doctors (called edge weight) was
the number of shared patients. On the basis of our preliminary
analyses and published data [3], we required that providers be
connected by at least two shared patients. Network construction
was performed in R version 2.12.0 using the igraph software
package [27].
Network subgroup deﬁnition
From these networks, we identiﬁed network subgroups. Sub-
groups deﬁne doctors who were more densely connected with
one another via shared patients than to doctors outside the
subgroup. Speciﬁcally, we used the Girvan-Newman algorithm
to deﬁne network subgroups (also called “community-struc-
tures”) [28]. In this approach, a betweenness score for each edge
was calculated. The betweenness score was proportional to the
number of shortest paths that ran along each edge, where the
shortest path represented the most direct route between a pair of
providers and accounted for edge weight. The algorithm then
removed the edge with the highest betweenness, thereby sepa-
rating the network into two smaller subgroups. Betweenness
scores were then recalculated and the process continued iter-
atively until a goodness-of-ﬁt test (modularity) was optimized
[29]. Each doctor was assigned to a single, mutually exclusive
subgroup. Patients, however, may have doctors who were
assigned to multiple subgroups. For our analyses, patients were
assigned to the network subgroup of the urologist who performed
their prostatectomy. We focused our investigation on network
subgroups with at least 20 patients to highlight the potential
importance of larger subgroups. Patients in network subgroups
with fewer than 20 patients were retained in the analyses in a
dummy category.
Network subgroup characteristics
For each network subgroup, we averaged the degree of the
treating urologists, where degree is deﬁned as the number of
other physicians with whom he or she shares patients. This
measure was dichotomized for interpretability with network
subgroups deﬁned as having a high average degree if they were
in the top 75% of the distribution in each city. The proportion of
nonwhite patients was calculated for each network subgroup.
Network subgroups were classiﬁed as having a high percentage of
nonwhite patients if the percentage was greater than the average
percentage of nonwhite patients in the city.Hospital assignment
Patients were assigned to the hospital where they received their
radical prostatectomy.
Statistical Analyses
After presenting univavariate analyses, we determined whether
network subgroup was associated with complications in multi-
variable analyses. To account for the correlation structure of
patients being nested within urologists and urologists being
nested within network subgroups, we used generalized linear
mixed-effect models for binary outcomes [30], where complica-
tion was the dependent variable and network subgroups was an
independent variable. We included ﬁxed effects for patient-level
covariates (age, comorbidity, Gleason grade, tumor stage,
prostate-speciﬁc antigen level, area-level median income, race
classiﬁed as either white or nonwhite), for the urologist-level
covariate (provider volume), and for subgroups, and random
effects for urologists. Analyses were performed separately for
each city and for each type of complication. To facilitate the
interpretation of these models, we generated the predicted
probability and 95% conﬁdence interval for each complication
and in each subgroup. We used the Bonferroni correction to
adjust for multiple testing in the ﬁve cities; thus, tests were
considered statistically signiﬁcant at P o 0.01. To examine the
percentage of variation explained by subgroups, we estimated the
intra-subgroup correlation coefﬁcients (ICCs) on the basis of the
logit scale of the complication rate [30].
In the second series of analyses, we examined whether network
subgroup characteristics were associated with odds of complica-
tions. For each complication, all cities were included in a single
model, and we used a generalized linear mixed-effects model with
ﬁxed effects for patient-level covariates, the urologist-level cova-
riate, network subgroup characteristics, and cities, and random
effects for urologists and network subgroups. The subgroup-level
predictors of interest were high average degree of urologists in the
subgroup and a high percentage of nonwhite patients.
In sensitivity analyses we sought to determine whether net-
work subgroups were signiﬁcantly associated with complications
after accounting for hospital assignment. In these models, we
considered hospital as a random effect. Data analysis was
performed using SAS (version 9.3, Cary, NC).Results
There were 2677 men in ﬁve cities with localized prostate cancer
who underwent radical prostatectomy in the analyses. The
sample in each city ranged in size from 270 to 1,224 men. The
sociodemographic characteristics of the sample are presented in
Table 1. Across the cities, we observed 30-day surgical complica-
tions in 23.4% of the men; 43.8% had late urinary complications,
and 8.3% had long-term urinary incontinence. Figure 1 presents
an example of a network formed by doctors who share patients
with one another.
In each city, subgroups of doctors who were densely con-
nected to one another were identiﬁed (Table 2). Cities had from 4
to 17 large network subgroups (with large deﬁned as at least 20
patients). The mean number of patients per large network
subgroup ranged from 34 in city 4 to 68 patients in city 2. The
mean number of urologists per network subgroup ranged from
3.8 urologists in city 3 to 10.5 in city 2. On average, there were
between 2.8 (city 3) and 6.8 (city 2) hospitals represented in each
network subgroup.
Table 3 presents results of unadjusted rates of complications
across network subgroups. The unadjusted rate of 30-day surgical
complications varied across network subgroups and by city from
Table 1 – Descriptive statistics, n (%) for overall sample and each city (2004–2005).
Characteristic Total: N (%):
2677 (100)
City 1
(n ¼ 448)
City 2
(n ¼ 1224)
City 3
(n ¼ 270)
City 4
(n ¼ 356)
City 5
(n ¼ 379)
Age (y)
65–69 1397 (52.2) 273 (60.9) 620 (50.7) 131 (48.5) 190 (53.4) 183 (48.3)
70–74 901 (33.7) 129 (28.8) 427 (35.0) 87 (32.2) 120 (33.7) 138 (36.4)
75þ 379 (14.2) 46 (10.2) 177 (14.4) 52 (19.3) 46 (12.9) 58 (15.3)
Comorbidity
0 841 (31.4) 117 (26.1) 351 (28.7) 97 (35.9) 135 (37.9) 141 (37.2)
1 846 (31.6) 143 (31.9) 347 (28.4) 106 (39.3) 122 (34.3) 128 (32.8)
2þ 990 (37.0) 188 (42.0) 526 (43.0) 67 (24.8) 99 (27.8) 110 (29.0)
Year of diagnosis
2004 1453 (54.3) 235 (52.5) 661 (54.0) 155 (57.4) 215 (60.4) 187 (49.3)
2005 1224 (45.7) 213 (47.5) 563 (46.0) 115 (42.6) 141 (39.6) 192 (50.7)
Gleason grade
o7 1096 (40.9) 178 (39.7) 519 (42.4) 137 (50.7) 127 (35.7) 135 (35.6)
7 1265 (47.3) 233 (52.0) 556 (45.4) 111 (41.1) 176 (49.4) 191 (49.9)
8–10 316 (11.8) 37 (8.3) 149 (12.2) 22 (8.2) 53 (14.9) 55 (14.5)
Tumor stage
2 2189 (81.8) 364 (81.3) 998 (81.5) 226 (83.7) 300 (84.3) 301 (79.4)
3 488 (18.2) 84 (18.8) 226 (18.5) 44 (16.3) 56 (15.7) 78 (20.6)
PSA level (ng/mL)
10þ 419 (15.7) 54 (12.1) 193 (15.8) 40 (14.8) 69 (19.4) 63 (16.6)
4.1–9.9 1521 (56.8) 244 (54.5) 706 (57.7) 154 (57.0) 206 (57.9) 211 (55.7)
r4 361 (13.5) 73 (16.3) 155 (12.7) 39 (14.4) 41 (11.5) 53 (14.0)
Unknown 376 (14.1) 77 (17.2) 170 (13.9) 37 (15.7) 40 (11.2) 52 (13.7)
Marital status
Married 2093 (78.2) 268 (59.8) 986 (80.6) 231 (85.6) 293 (82.3) 315 (83.1)
Unmarried 438 (16.4) 69 (15.4) 226 (18.5) 25 (9.3) 452 (414) 454 (414)
Unknown 146 (5.5) 111 (24.8) 12 (1.0) 14 (5.2) o11 (o4)* o11 (o3)*
30-d surgical complication 625 (23.4) 84 (18.8) 310 (25.3) 51 (18.9) 78 (21.9) 102 (26.9)
Late urinary complication 1173 (43.8) 154 (34.4) 631 (51.6) 102 (37.8) 113 (31.7) 173 (45.6)
Long-term incontinence 222 (8.3) 24 (5.4) 124 (10.1) 18 (6.7) 29 (8.2) 27 (7.1)
PSA, prostate-speciﬁc antigen; SEER, Surveillance, Epidemiology and End Results.
* Cell sizes masked because of small sample sizes and SEER-Medicare restrictions regarding conﬁdentiality. Racial and income composition of
subgroups not shown in table because of conﬁdentiality restrictions.
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across network subgroups in city 4 to a 31.2 percentage-point
difference in city 5. Differences in the rates of late urinary
complications ranged from 32.1 to 72.5 percentage points across
network subgroups within cities, and differences in the rates of
long-term incontinence ranged from 6.7 to 36.8 percentage
points. These reached statistical signiﬁcance for 30-day surgical
complications in city 3, for late urinary complications in cities 2,
3, and 5, and for long-term incontinence in city 2.
Figure 2 presents the estimated mean complication rates for
men receiving their prostatectomy from urologists in different
network subgroups, controlling for patient-level characteristics
and provider volumes. The results show varying rates of compli-
cations across network subgroups within each city, though with
overlapping conﬁdence intervals. From the regression models,
the overall network subgroup term was signiﬁcant (P o 0.001) for
30-day surgical complications in cities 2 and 3; there were
signiﬁcant differences in rates of late urinary complications
among network subgroups in cities 2, 3, and 5; and for long-
term incontinence, there were signiﬁcant differences among
network subgroups in cities 1, 2, 4, and 5. The ICCs indicate that
network subgroups explained up to 13.5% of the variation in 30-
day complications (city 3), up to 31.3% of the variation in late
urinary complications (city 3), and up to 14.7% of the variation in
long-term incontinence (city 1).
In models that examined characteristics of network sub-
groups, average urologist degree was signiﬁcantly associatedwith 30-day surgical complications and long-term incontinence
(P values for overall subgroup term 0.010 and o0.0001, respec-
tively), and the proportion of nonwhite patients in a network
subgroup was signiﬁcantly associated with long-term inconti-
nence (P o 0.001). Not all associations with network character-
istics, however, were in the same directions. For example,
average urologist degree was associated with signiﬁcantly lower
30-day complications in city 3 but higher long-term incontinence
in city 4 (see Appendix Table 1 in Supplemental Materials found
at http://dx.doi.org/10.1016/j.jval.2014.04.011).
In analyses in which we adjusted for clustering by hospital,
we continued to observe signiﬁcant associations between net-
work subgroups and complications. In these models, hospitals
accounted for up to 11.2% of variations in 30-day surgical
complications (city 3), 13.8% for late urinary complications (city 3),
and 12.3% for long-term incontinence (city 2).Discussion
Within each city, it is possible to use network analytic techniques
to identify subgroups of doctors who are more likely to share
patients with one another. These network subgroups may
explain a portion of the observed variation in surgical complica-
tions after radical prostatectomy, and, despite the small sample
sizes, comparisons among some subgroups remained signiﬁcant
after accounting for patient-level characteristics and adjusting
Fig. 1 – An example patient-sharing network for city 1. The
1904 physicians are represented by circles; they are
connected by shared patients represented by lines and
including all patients without metastatic cancer regardless
of whether they received surgery or not. Network subgroups
are shaded different colors. The location of physicians is
determined by social distance using the Fruchterman-
Reingold layout.
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nature, raise a number of important questions.
First, what might network subgroups represent in terms of
health care delivery? Previous work on quality of cancer care has
tended to focus on the individual provider (e.g., provider volume)
[13–15] or on features of the hospital system (e.g., percentage of
minority patients [31], status as a National Cancer Institute–
designated cancer center [32,33], and hospital volume [14]). In
contrast, network subgroups are deﬁned by doctors who are
tightly “connected” to one another through shared patients and
may represent doctors who are formally connected to one (e.g.,
through practice structure, hospital afﬁliation) as well as infor-
mally (e.g., by referral patterns and advice seeking) [3,6].
Although associated with practice structure, network sub-
groups typically encompass doctors from multiple practices [6].
SEER-Medicare data remove tax identiﬁcation numbers that areTable 2 – Descriptive characteristics of the network struc
Characteristic City 1 City
No. of patients 448 1224
No. of urologists 80 206
No. of large network subgroups* 7 17
Average number of patients per large
network subgroup (range)
57.4 (21–148) 68.4
Average number of urologists per large
network subgroup (range)
8.7 (3–22) 10.5
Average number of hospitals per large
network subgroup (range)
4.7 (1–9) 6.8
* Large network subgroups are deﬁned as having at least 20 patients.sometimes used to group physicians into practices [26]; thus,
having alternative techniques to group providers may be useful.
Similarly, we ﬁnd that although patients who received their
surgery at the same hospital tended to be in the same subgroup,
subgroups often encompass patients seen at multiple hospitals.
Moreover, with a large proportion of cancer care occurring in the
outpatient setting, it may be challenging to group providers into
hospital-based networks [34]. The current strategy may represent
a promising approach to delineating naturally occurring net-
works of physicians, reﬂecting the ways that health care is
delivered in practice [4]. As discussed later, however, the optimal
approach to constructing patient sharing networks has not been
determined; the approach may vary across cancer types, data
sets, and outcomes, meriting future validation.
Second, why might network subgroups be associated with
rates of surgical complications? One explanation may be that
doctors of higher or lower quality tend to be connected to one
another [35]. Previous work has suggested that “high-status”
doctors may be most likely to refer to one another [36]. Thus,
high-quality doctors may be more likely to share patients with
other high-quality doctors and be placed in the same subgroup.
An overlapping explanation is that the practice style of one
physician in a network subgroup may affect (either positively or
negatively) the style of another physician in the subgroup [37].
Literature on the diffusion of innovation suggests that doctors
who are important in the network structure may have a large
effect on medical adoption [38,39]. This diffusion may occur
through direct care of a particular patient or through informal
consultations [40]. It is plausible that these may affect technical
aspects of care and speciﬁc surgical techniques that are used. We
would expect this effect to be most pronounced for urologists
who are directly connected to one another. Urologists who are
connected through PCPs or other providers, however, may also
induce behavior change through cooperation (e.g., through insti-
tutional structures) or competition (e.g., for referrals from PCPs).
A related explanation is, to the extent that network subgroups
reﬂect practice structure and hospital afﬁliation, that rates of
complications may stem from the underlying context of differing
institutional resources and practices. The context of network
subgroups may further be shaped by participation in different
insurance networks and by other area-level factors.
Selection effects may occur at multiple levels and help explain
the observed associations between network subgroups and com-
plications. Patients may select physicians (and network sub-
groups) with varying propensities to screen for prostate cancer,
diagnose the disease, and operate on surgical candidates [6]. A
large portion of patients with prostate cancer who undergo
radical prostatectomy have a different diagnosing and treating
urologist [41]; it is uncertain the extent to which this represents
patient choice, provider referrals patterns, and/or other factors.ture in ﬁve cities (2004–2005).
2 City 3 City 4 City 5
270 356 379
29 92 64
4 9 9
(20–203) 44.3 (30–56) 34.0 (20–49) 37.6 (21–57)
(2–25) 3.8 (1–8) 7.2 (4–12) 5.9 (3–13)
(1–15) 2.8 (1–6) 4.1 (2–7) 3.2 (1–6)
Table 3 – Average rates of complications and chi-squared test for variation across network subgroups within
cities (2004–2005).
Complication City 1 City 2 City 3 City 4 City 5
% P % P % P % P % P
30-d surgical
complications
18.8 25.3 18.9 21.9 26.9
Range* 8.8–31.7 0.049 11.1–37.7 0.307 5.0–26.9 0.005 12.0–32.7 0.489 14.3–45.5 0.047
Late urinary
complications
34.4 51.6 37.8 31.7 45.7
Range* 25.0–57.1 0.242 31.3–91.2 o0.001 10.0–82.5 o0.001 15.8–48.8 0.031 17.1–71.4 o0.001
Long-term
incontinence
5.4 10.1 6.7 8.2 7.1
Range* 0.0–19.5 0.023 0.0–36.8 o0.001 3.3–10.0 0.803 0.0–12.2 0.413 0.0–14.3 0.609
* Indicates range across subgroups. P o 0.01 is considered signiﬁcant after correcting for ﬁve different cities.
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the subgroups? Within each city, speciﬁc subgroups did not
invariably have high rates of complications across the three
complications and the proportion of variance explained by sub-
groups was relatively modest. The results suggest that the
importance of subgroups in explaining radical prostatectomy
complications may be one of many factors (e.g., technical skill
of the surgeon), and the potential mechanisms through which
networks are associated with health may vary depending on the
particular type of complication. The ﬁndings were not consistent
across the cities, potentially indicating that other aspects of the
local health care delivery and/or network structure may help
shape these associations.
Fourth, what characteristics of speciﬁc subgroups are associ-
ated with quality of care? We found some evidence that average
urologist degree, a marker of importance, was associated with
complications as was the subgroup racial composition; however,
within cities, not all associations were in the expected directions.
The reasons for these divergent ﬁndings are uncertain and
suggest the need for additional research into the characteristics
of physician patient-sharing networks. Examining the associa-
tion between physician-speciﬁc measures of his or her network
position and complications may also be a promising line of
research.
Finally, how might this type of approach be deployed when
trying to improve quality? If validated, the ability to identify
subgroups may help target interventions to groups of physicians
with the highest rates of speciﬁc types of complications. As noted
above, these subgroups may be related to, albeit distinct from,
approaches that target speciﬁc practices or hospitals [4]. Within
each subgroup, quality improvement initiatives may be facili-
tated by working with speciﬁc providers within the network
structure [37]. This builds on and complements the tradition of
identifying key opinion leaders from surveys to promote the
adoption of best practices [42,43]. Interventions may focus on
doctors that are central in a subgroup to facilitate the spread of
norms and quality standards or alternatively on doctors on the
periphery who may be early adopters of new technology
[39,44,45].
This work has several limitations. The optimal approach to
constructing physician patient-sharing networks and identifying
network subgroups has not been developed. By limiting our
analyses to speciﬁc cities, we create a “boundary speciﬁcation
problem” in which patients nearby the city’s boundaries may
alter the network structure [46]. We considered providers to be
connected to one another if they shared two patients. Network
structure and associations with complications were largelyconsistent when lowering the threshold to one patient; increas-
ing the threshold to three patients resulted in many fewer
physicians being connected to one another (see Appendix
Table 2 in Supplemental Materials found at http://dx.doi.org/10.
1016/j.jval.2014.04.011). Adding more years of data to test the
stability and evolution of networks over time and including
patients who do not have cancer but are nonetheless shared by
providers may prove useful in generating more robust depictions
of health care delivery.
Additional limitations stem from the use of claims data. First,
Medicare claims have been shown to have a high sensitivity and
speciﬁcity for surgical [47,48] and late urinary complications [13].
In contrast, ascertainment of incontinence has a 39% sensitivity
compared with self-report but high speciﬁcity (92%) [13].
Although we substantially underestimate the incidence of long-
term incontinence, our goal was not to determine the complica-
tion rate but to assess how the rate of complications differs
according to subgroup. There is no evidence that the ascertain-
ment of complications would be differential between subgroups.
Second, we were unable to include patients younger than 65
years, those without a diagnosis of prostate cancer, and men
enrolled in health maintenance organizations in our construction
of patient-sharing networks. Although Medicare urologist volume
is highly correlated with total patient volume [13], the exclusion
of these patients may alter the network structure by reducing the
number of shared patients between doctors. Third, we were
unable to match all patients to their diagnosing urologist.
Patients who did not match were similar to those who did on
observable characteristics; however, the proportion of patients
who did not match ranged from 3.9% to 9.5% across the cities.
The effect of this on our network structure remains uncertain.
Fourth, though we adjust for surgical volume, incomplete adjust-
ment for surgical technique and surgeon’s experience may bias
our ﬁndings. Fifth, though we test models that include hospital
structure, we recognize that the models are unable to account for
practice structure, which may be an important determinant of
complication rates. Sixth, this observational analysis is unable to
determine causality, and, as noted above, selection effects may
be an important contributor to our ﬁndings. Finally, the small
sample sizes in some network subgroups may have led to
unstable estimates in some instances and limited our ability to
detect clinically meaningful differences.
In summary, physician networks based on shared patients are
associated with variation in rates of complications after radical
prostatectomy for prostate cancer. Physician patient-sharing
networks may be useful tools to better understand cancer care
variation within and across geographic regions.
Fig. 2 – Estimated mean rates of complications with 95% conﬁdence intervals by network subgroup across ﬁve cities. The
subgroups are ordered by size (number of patients) from biggest to smallest. Subgroup number 99 in each city represents
patients who were assigned to subgroups with fewer than 20 patients; these patients were retained as a dummy category.
Marginal probabilities were estimated on the basis of population-average model [49] given the following covariates: age ¼ 65
to 69 years, comorbidity ¼ 2þ, Gleason grade ¼ 7, tumor stage ¼ 2, PSA level ¼ 4.1–9.9 ng/mL, median area income ¼ second
lowest quartile, white race, marital status ¼ married, and provider surgical volume ¼ low. PSA, prostate-speciﬁc antigen.
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